Enzon Pharmaceuticals, Inc. (ENZND)

4.03 -1.85 (-31.46%) USD  |  OTCM  |  Mar 25, 16:00
More

Enzon Pharmaceuticals EPS Diluted (Quarterly YoY Growth)

EPS Diluted (Quarterly YoY Growth) Chart

View EPS Diluted (Quarterly YoY Growth) for ENZND.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly YoY Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years

View EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly YoY Growth) Benchmarks

View EPS Diluted (Quarterly YoY Growth) Benchmarks
Start Trial
Agenus, Inc. Upgrade
Curis, Inc. Upgrade
Windtree Therapeutics, Inc. Upgrade
Halozyme Therapeutics, Inc. Upgrade
AIM ImmunoTech, Inc. Upgrade